Skip to main content
. 2024 Mar 13;22:26. doi: 10.1186/s12955-024-02227-0

Table 4.

Factors influencing health-related quality of life among hospitalized cancer cases in India

Parameter B Std. Error 95% Confidence Interval p-value*
Lower Upper
(Intercept) 0.500 0.038 0.426 0.574 0.000
Age -0.002 0.000 -0.003 -0.001 0.000
Hospital Days -0.003 0.002 -0.006 0.000 0.060
Type of Hospital (Reference - Public) Semi-private 0.231 0.016 0.200 0.263 0.000
Education (Refernce- No Education) Primary & Middle 0.031 0.020 -0.009 0.071 0.133
Up to Senior Secondary 0.031 0.021 -0.009 0.072 0.128
Graduation & above 0.075 0.023 0.030 0.120 0.001
Type of Cancer (Reference-Solid) Haematological -0.033 0.027 -0.086 0.020 0.218
Type of Treatment (Reference- Chemotherapy) Radiotherapy -0.025 0.033 -0.090 0.039 0.440
Palliative care -0.258 0.056 -0.367 -0.149 0.000
Surgery -0.127 0.033 -0.192 -0.062 0.000
Combination Therapy** -0.133 0.024 -0.181 -0.085 0.000
Maintenance Therapy -0.702 0.151 -0.998 -0.406 0.000
On diagnostic workup -0.144 0.037 -0.216 -0.072 0.000
Hormone Therapy -0.163 0.184 -0.523 0.198 0.377
Immunotherapy 0.098 0.062 -0.022 0.219 0.110
Others (clinical follow up) -0.136 0.029 -0.193 -0.080 0.000
Line of Treatment (Reference - First Line) Second Line -0.065 0.025 -0.114 -0.017 0.008
Third Line 0.037 0.062 -0.084 0.158 0.550
Fourth Line 0.117 0.104 -0.086 0.321 0.258
Response to Treatment (Reference– Disease free survival) Progressive -0.149 0.040 -0.227 -0.071 0.000
Ongoing 0.016 0.024 -0.031 0.064 0.504
Adverse Effect (Reference - With Adverse Effect) Without Adverse Effect 0.085 0.025 0.037 0.133 0.001

*Level of significance at p- value less than 0.05, **Combination therapy– Chemotherapy + Radiotherapy, Surgery + Radiotherapy, Surgery + Chemotherapy, Surgery + Chemotherapy + Radiotherapy. Ongoing treatment-response cannot be assessed among patients on active oncology treatment